Health tech company Inato developed an AI-powered patient prescreening tool to make it easier and faster for research sites to assess patient eligibility for clinical trial opportunities.
Patient enrollment is a major bottleneck for trials. The patient prescreening process takes 25% longer today compared to five years ago—and growing trial complexity, larger trials and increasing competition for participants threaten to exacerbate this problem.